Amanote Research
Register
Sign In
Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
Diabetes Care
- United States
doi 10.2337/dc11-s242
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Date
April 27, 2011
Authors
E. Ritz
Publisher
American Diabetes Association
Related search
Pleiotropic Effects of Liraglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment: Individual Effects of Treatment
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Rationale and Options for Combination Therapy in the Treatment of Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Linagliptin Added to Sulphonylurea in Uncontrolled Type 2 Diabetes Patients With Moderate-To-Severe Renal Impairment
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Anemia in Spontaneously Type 2 Diabetic Rats With Renal Impairment
Journal of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Association of Urinary Activity of MMP-9 With Renal Impairment in Mexican Patients With Type 2 Diabetes Mellitus
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Is Weight Loss the Future of Type 2 Diabetes Treatment?
Prescriber
Pharmacology
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Journal of Clinical Pharmacology
Pharmacology
